INPHARMATICA
Inpharmatica specialises in the use of predictive informatics in medicinal chemistry and ADME to improve the speed and productivity of drug discovery. Founded in 1998, the company employs around 35 professionals at its UK locations in London and Cambridge. Inpharmatica’s unique proprietary technologies and skills are utilised in major discovery laboratories worldwide and use natural materials for health. Inpharmatica is unique in offering discovery technologies and services which span the full breadth of research from target through to candidate selection: the core elements are fully integrated, enabling customers to access its end-to-end technologies, or individual components and services as required.
INPHARMATICA
Industry:
Biotechnology Health Care Medical
Founded:
1997-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.inpharmatica.co.uk
Total Employee:
101+
Status:
Active
Contact:
44 20 7074 4600
Email Addresses:
[email protected]
Total Funding:
75.49 M USD
Technology used in webpage:
SSL By Default IPv6 Cloudflare Cloudflare Hosting Cloudflare Network Error Logging Cloudflare DNS Cloudflare SSL
Similar Organizations
Bionime
Bionime is a specialized in the business of biotechnology and medical testing.
E-Swin
E-Swin is specializes in pulsed light for aesthetic and medical use.
RITVERC GmbH
RITVERC GmbH is a company that specializes in research on radioisotopes for medicine and industry.
Investors List
REV
REV investment in Series C - Inpharmatica
Vertex Management
Vertex Management investment in Series B - Inpharmatica
Dresdner Kleinwort
Dresdner Kleinwort investment in Series B - Inpharmatica
Abingworth
Abingworth investment in Series B - Inpharmatica
Official Site Inspections
http://www.inpharmatica.co.uk
- Host name: 104.21.75.153
- IP address: 104.21.75.153
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Inpharmatica"
Inpharmatica - Crunchbase Company Profile & Funding
Inpharmatica specialises in the use of predictive informatics in medicinal chemistry and ADME to improve the speed and productivity of drug discovery. …See details»
Inpharmatica - 2025 Company Profile - Tracxn
Inpharmatica has developed a platform that uses predictive informatics in medicinal chemistry and ADME for drug discovery. The Chemagenomics platform is used for in silico target selection …See details»
Inpharmatica Company Profile | Management and Employees List
Founded in 1998, the company employs around 35 professionals at its UK locations in London and Cambridge. Inpharmatica's unique proprietary technologies and skills are utilised in major …See details»
Inpharmatica 2025 Company Profile: Valuation, …
Information on acquisition, funding, cap tables, investors, and executives for Inpharmatica. Use the PitchBook Platform to explore the full profile.See details»
Galapagos (Acquired Inpharmatica) - VentureRadar
Find out more about Galapagos (Acquired Inpharmatica), Life Sciences and Healthcare, Healthcare, Chemiinformatics, Bioinformatics and Healthtech and Life Sciences and .See details»
Chematica
Chematica Integrates biology and chemistry to fast-track target and lead selection Chematica is a powerful proprietary informatics approach to drug discovery, which combines the chemical and …See details»
Inpharmatica Ltd., Cambridge UK - life-sciences-europe.com
Inpharmatica is a privately held drug discovery company. Founded in 1998, the company employs around 30 people at its UK locations in London and Cambridge. Major investors include 3i, …See details»
Inpharmatica - Overview, News & Competitors | ZoomInfo.com
View Inpharmatica (www.inpharmatica.co.uk) location in United Kingdom , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Inpharmatica Company Profile - Office Locations, Competitors ...
See insights on Inpharmatica including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Inpharmatica Ltd - selectscience.net
Inpharmatica Ltd Inpharmatica specialises in the use of predictive informatics in genomics, medicinal chemistry and ADME to improve the speed and productivity of drug discovery. …See details»
INPHARMATICA'S ADMENSA INTERACTIVEâ„¢ LICENSED BY LILLY
Jun 30, 2006 The company employs around 90 professionals at its UK locations in London and Cambridge, with business development in North America and Japan. Inpharmatica’s unique …See details»
Inpharmatica Ltd. - life-sciences-europe.com
Inpharmatica is a privately held drug discovery company. Founded in 1998, the company employs around 30 people at its UK locations in London and Cambridge. Major investors include 3i, …See details»
Inpharmatica - Products, Competitors, Financials, Employees ...
About Inpharmatica Inpharmatica specializes in the use of predictive products and services in medicinal chemistry and ADME to improve the speed and productivity of drug discovery. It …See details»
Inpharmatica Ltd. - | BioWorld
Jan 1, 2002 Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, …See details»
Products and Services - inpharmatica.co.uk
Products and Services Overview Inpharmatica applies a knowledge-based, validated predictive strategy focusing on selected drug targets, leads and candidates. This strategy is designed to …See details»
Inpharmatica Ltd, Research Institutions And Organisations In …
Be the first to review 60 Charlotte Street London Greater London W1T 2NU Show map Show me directions to Inpharmatica LtdInpharmatica Ltd, Research Institutions And Organisations In …See details»
Galapagos (Acquired Inpharmatica) | VentureRadar
Acquired/Merged "Inpharmatica specialises in the use of predictive products and services in medicinal chemistry and ADME to improve the speed and productivity of drug discovery.See details»
InPharmatica licenses AI to Eli Lilly & Co - The Pharma Letter
Jul 9, 2006 UK-based drug discovery specialists Inpharmatica says that it has agreed a deal with US major Eli Lilly which grants the latter a license for Admensa Interactive, the former's suite …See details»
Prince Harry Accused of ‘Bullying’ by Chair of Charity He Co-founded
11 hours ago An ugly rift between Prince Harry and a leader of a charity he co-founded escalated on Sunday after the leader, Sophie Chandauka, accused the prince of engaging in …See details»
Pharmacies to provide more frontline healthcare after £3bn …
20 minutes ago Pharmacies to provide more frontline health services after £3bn funding boost After a year of negotiations between pharmacies and Tory and Labour governments, health …See details»